Sofregen Medical Inc
At Sofregen, we provide medical practitioners with natural biomaterials to enhance their surgical artistry and achieve more durable results for their patients. We aim to unlock the enormous potential of purified silk protein to facilitate soft tissue regeneration for a range of aesthetic procedures and surgeries including vocal fold medialization and insufficiency. Sofregen is a pioneer in soft tissue engineering with an advanced platform based on silk protein, also known as fibroin, which has been shown to have unique properties for tissue support and regeneration. Sofregen’s Silk platform is carefully engineered to match the biomechanics of soft tissue for immediate bulking and long-term tissue replacement.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Nationally (across the country)
About Us
Our story begins in the research laboratories of the Biomedical Engineering Department at Tufts University, where pioneering scientists focus on new ways to engineer silk protein for medical impact.
We provide medical practitioners with natural biomaterials to enhance their surgical artistry and achieve more durable results for their patients. We are focused on unlocking the enormous potential of purified silk protein to facilitate soft tissue regeneration for a range of aesthetic procedures and surgeries.
Silk Voice® Injectable Implant , a breakthrough silk and hyaluronic acid injectable implant, was cleared by the U.S. FDA in 2019. Silk Voice® is indicated for vocal fold medialization and vocal fold insufficiency that may be improved by injection of a soft tissue bulking agent.
SERI® Surgical Scaffold, a breakthrough silk-based implantable biological scaffold, was cleared by the U.S. FDA in 2013. Sofregen acquired SERI® Surgical Scaffold in late 2016 to advance this technology and other silk protein-based pipeline products in a broad range of aesthetic procedures requiring tissue support.
This is just the beginning.
We are in the advanced stages of developing a portfolio of silk-based implantable and injectable products that will become a force for regenerative beauty.
In the future, Sofregen will bring to market a range of unique silk-based devices for surgeons, aesthetic practitioners and other specialists.
Focus
Unlocking the potential of biomedical silk protein in soft tissue regeneration
VISION
Becoming a force for beauty in the hands of skilled medical aesthetic practitioners
PIPELINE
Advancing silk protein science for use in injectable fillers